Form 4: HealthStream Director Sells HSTM Shares

HealthStream Director Deborah Taylor Tate sold 1,580 shares of common stock for a weighted average price of $25.46 per share under a Rule 10b5-1 plan.

Summary

• Deborah Taylor Tate, a Director of HealthStream Inc. (HSTM), reported a sale of common stock.
• The transaction involved the disposition of 1,580 shares of common stock.
• The shares were sold at a weighted average price of $25.46 per share, with individual trades ranging from $25.40 to $25.53.
• Following this transaction, Deborah Taylor Tate beneficially owns 23,127 shares of HealthStream common stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was pre-scheduled.

Sentiment

Score: 5

Explanation: This Form 4 reports a routine insider stock sale under a pre-arranged 10b5-1 plan, which is generally considered neutral and does not inherently indicate positive or negative sentiment about the company's future prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction report is a routine disclosure required by the SEC for company directors, officers, and significant shareholders. It does not provide information directly related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: A director's sale, especially when executed under a Rule 10b5-1 plan, is typically a routine event and is unlikely to have a significant impact on shareholder sentiment or the company's operational outlook.

Key Dates

Keywords

HealthStream, HSTM, Insider Trading, Form 4, Stock Sale, Director, Deborah Taylor Tate, Rule 10b5-1